← FDA DRUG APPROVALS

FDA ANDA · ANDA040299

DEXTROAMPHETAMINE SULFATE

Sponsor: STRIDES PHARMA INTL

APPLICATION
ANDA040299
TYPE
ANDA
ORIGINAL APPROVAL
1999-05-13
LATEST ACTION
2023-10-13
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

DEXTROAMPHETAMINE SULFATEDiscontinued
DEXTROAMPHETAMINE SULFATE 5MG · TABLET · ORAL

Approval history

2023-10-13Labeling · Supplement 5 · standardAP
2022-02-25Labeling · Supplement 4 · standardAP
2017-01-04Labeling · Supplement 3 · standardAP
2015-04-17Labeling · Supplement 2 · standardAP
2002-07-18Manufacturing (CMC) · Supplement 1AP
1999-05-13OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →